Neo-adjuvant chemotherapy followed by radical resection for primary borderline resectable unicentric Castleman disease: a case report

Here we introduced a successful case showing neo-adjuvant chemotherapy followed by radical resection for a borderline resectable unicentric Castleman disease (UCD). This study demonstrated that neo-adjuvant rituximab in combination with cyclophosphamide, epirubicin, vincristine and prednisone (R-CHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Hongkai, Ma, Zuyi, Wu, Yanxia, Yin, Zi, Jian, Zhixiang, Zhang, Chuanzhao, Hou, Baohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799261/
https://www.ncbi.nlm.nih.gov/pubmed/35117662
http://dx.doi.org/10.21037/tcr.2020.02.45

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799261/
https://www.ncbi.nlm.nih.gov/pubmed/35117662
http://dx.doi.org/10.21037/tcr.2020.02.45

Ejemplares similares